Click Here to return To Results

 

Efficacy and Safety of Everolimus for Subependymal Giant Cell Astrocytomas Associated with Tuberous Sclerosis Complex (EXIST-1): A Multicenter, Randomized, Placebo-Controlled Phase 3 Trial Lancet 381:125-132, Franz, D.,et al, 2013 See this aricle in Pubmed Article Abstract These results support the use of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis. Additionally, everolimus might represent a disease-modifying treatment for other aspects of tuberous sclerosis.

Related Tags

(click to filter results - removes previous filter) astrocytoma efficacy everolimus genetic neurologic disorders neoplasm,primary intracerebral safety treatment of neurologic disorder tuberous sclerosis

Click Here to return To Results